Director of Financial Planning and Analysis

Director of Financial Planning and Analysis Veradermics is a late clinical-stage aesthetics and dermatology focused biopharmaceutical company developing first-in-class therapeutics for common dermatologic conditions. Fresh off a $75 million Series B financing, we are entering an exciting new chapter as we advance lead candidate VDPHL01, a non-hormonal oral therapeutic for androgenetic alopecia (AGA) and patterned hair loss (PHL). We are currently in late-stage Phase 2 development with Phase 3 preparations underway. Our pipeline also addresses conditions like common warts and molluscum contagiosum. Veradermics aims to redefine the standard of care in dermatology by combining scientific rigor with impactful innovation. You Can Be Part of a Meaningful Mission - Veradermics aims to create a paradigm shift in medical dermatology by bringing pharmaceutical innovation to skin conditions that lack meaningful therapeutic advances. Veradermics Has Significant Growth Potential – Product Candidates Have Cumulative Revenue Estimates of > $6B/Year. We have been featured in Forbes, Slate, The New York Post, The Hartford Courant, The Kansas City Star, and many other media outlets. Director, FP&A | Position Overview The Director of FP&A will serve as a hands-on leader and sole contributor initially, reporting directly to the CFO. This role will establish foundational FP&A processes, deliver accurate and timely insights, and serve as a trusted partner to executives and functional leaders. The position is highly visible, with significant impact on strategic decision-making and capital market readiness. Design and implement core FP&A processes for planning, forecasting, and reporting. Lead the annual budget cycle, quarterly forecasts, and variance analysis. Develop dashboards, models, and KPIs to track financial health (P&L, operating expenses, cash runway). Build and maintain complex scenario-based models integrating R&D milestones, clinical trial timelines, and commercial projections. Support clinical program financial planning, including accrual tracking and study-level transparency in collaboration with accounting. Conduct ad hoc scenario planning, ROI analyses, and resource optimization to support strategic decision making. Analytics & Insights Monitor and interpret KPIs such as burn rate, budget-to-actuals, and long-range planning. Ensure accuracy of master data and develop processes to capture and analyze CRO and clinical trial data. Provide actionable insights that align finance with operational strategy. Partner with R&D, Clinical, and Medical Affairs leaders to explain cost drivers and forecast assumptions. Build regular business review touchpoints with VPs and department heads. Collaborate with the Controller on G&A planning and long-range modeling. Serve as a strategic thought-partner on high-impact initiatives, driving scenario planning, investment analysis, and resource optimization. Candidate Profile | Who You Are 8+ years of progressive FP&A or finance experience; biotech/life sciences strongly preferred. Proven track record of supporting R&D and clinical development organizations. Experience in high-growth or pre-commercial environments. Advanced Excel and financial modeling expertise; ERP system proficiency required (NetSuite experience a plus). Hands-on experience building processes, implementing systems, and improving data integrity. Strong communicator with the ability to influence senior stakeholders. Strategic thinker with adaptability, ownership, and problem-solving mindset. Location New Haven, Connecticut - hybrid role requiring 1-2 days per week in the New Haven office. Salary and Benefits Veradermics provides a comprehensive compensation package that includes a base salary, annual performance bonus eligibility, and access to the employee stock option plan. Robust benefits package including health coverage, retirement benefit matching, dependent care FSA, and unlimited paid time off. Equal Opportunity Employer Veradermics is an equal opportunity employer. All employment decisions are based on qualifications, merit, and business needs, without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, disability, or age. #J-18808-Ljbffr

Created: 2025-09-26